BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9592878)

  • 21. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
    Duerr HP; Eichner M
    Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge, attitude and practice of community drug distributors' about onchocerciasis and community directed treatment with ivermectin in Quara district, North Western Ethiopia.
    Weldegebreal F; Medhin G; Weldegebriel Z; Legesse M
    BMC Res Notes; 2016 Apr; 9():206. PubMed ID: 27053243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The onchocerciasis chronicle: from the beginning to the end?
    Crump A; Morel CM; Omura S
    Trends Parasitol; 2012 Jul; 28(7):280-8. PubMed ID: 22633470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards the elimination of onchocerciasis.
    Thylefors B; Alleman M
    Ann Trop Med Parasitol; 2006 Dec; 100(8):733-46. PubMed ID: 17227651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
    Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
    Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Partnerships and the distribution of Mectizan. Ministries of health].
    Ndoyo J
    Sante; 1998; 8(1):66-7. PubMed ID: 9592886
    [No Abstract]   [Full Text] [Related]  

  • 27. [Distribution and treatment using ivermectin under community directives].
    Diarra T
    Sante; 1998; 8(1):81-3. PubMed ID: 9592891
    [No Abstract]   [Full Text] [Related]  

  • 28. [Partnerships for prolonged success in onchocerciasis control in Guinea].
    Diallo NK
    Sante; 1998; 8(1):70-1. PubMed ID: 9705649
    [No Abstract]   [Full Text] [Related]  

  • 29. Human onchocerciasis--an overview of the disease.
    Duke BO
    Acta Leiden; 1990; 59(1-2):9-24. PubMed ID: 2198761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control.
    World Health Organ Tech Rep Ser; 1995; 852():1-104. PubMed ID: 7541171
    [No Abstract]   [Full Text] [Related]  

  • 32. Research for control: the onchocerciasis experience.
    Remme JH
    Trop Med Int Health; 2004 Feb; 9(2):243-54. PubMed ID: 15040562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.
    Plaisier AP; Alley ES; van Oortmarssen GJ; Boatin BA; Habbema JD
    Bull World Health Organ; 1997; 75(3):237-45. PubMed ID: 9277011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Onchocerciasis Control Programme in West Africa (OCP).
    Boatin B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():13-7. PubMed ID: 18718148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa.
    Siewe Fodjo JN; Mubiru F; Ukaga C; Logora MY; Mmbando BP; Mandro M; Njamnshi AK; Colebunders R
    Int Health; 2020 Jan; 12(1):72-75. PubMed ID: 31251354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Onchocerciasis control program in Chad: the Mectizan donation].
    Namangué K
    Sante; 1998; 8(1):51-2. PubMed ID: 9592880
    [No Abstract]   [Full Text] [Related]  

  • 40. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
    Awadzi K; Dadzie KY; Kläger S; Gilles HM
    Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.